NAB2, NGFI-A binding protein 2, 4665

N. diseases: 65; N. variants: 5
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0018922
Disease: hemangiopericytoma
hemangiopericytoma
0.380 AlteredExpression disease BEFREE 'Papillary' solitary fibrous tumor/hemangiopericytoma with nuclear STAT6 expression and NAB2-STAT6 fusion. 26746203 2016
CUI: C1266119
Disease: Solitary fibrous tumor
Solitary fibrous tumor
0.600 GeneticVariation disease BEFREE Solitary fibrous tumor is a mesenchymal neoplasm exhibiting a broad spectrum of biological behavior and harboring the NAB2-STAT6 fusion. 27562490 2016
CUI: C1266119
Disease: Solitary fibrous tumor
Solitary fibrous tumor
0.600 GeneticVariation disease BEFREE Solitary fibrous tumors (SFTs) are rare mesenchymal tumors commonly located in the pleura, soft tissues, or meninges and are characterized by the NGFI-A-binding protein 2 (NAB2)-signal transducer and activator of transcription 6 (STAT6) fusion gene. 28914981 2018
CUI: C1266119
Disease: Solitary fibrous tumor
Solitary fibrous tumor
0.600 Biomarker disease BEFREE Solitary fibrous tumour (SFT) is an infrequently metastasising mesenchymal tumour defined by the <i>NAB2-STAT6</i> fusion gene. 29703757 2018
CUI: C1266119
Disease: Solitary fibrous tumor
Solitary fibrous tumor
0.600 GeneticVariation disease BEFREE Solitary fibrous tumors (SFTs) are NAB2-STAT6 fusion-associated neoplasms. 31321477 2019
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate
0.120 PosttranslationalModification disease BEFREE NAB2 and CDC6 were hypermethylated frequently in pCA (92%, 67%, respectively) and in BPH (91%, 59%, respectively). 16956712 2007
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.020 PosttranslationalModification disease BEFREE NAB2 and CDC6 were hypermethylated frequently in pCA (92%, 67%, respectively) and in BPH (91%, 59%, respectively). 16956712 2007
CUI: C0349622
Disease: Hemangiopericytoma of meninges
Hemangiopericytoma of meninges
0.020 Biomarker disease BEFREE NAB2-STAT6 fusion gene analysis in two cases of meningeal solitary fibrous tumor/hemangiopericytoma with late distant metastases. 25893823 2015
CUI: C2939419
Disease: Secondary Neoplasm
Secondary Neoplasm
0.010 Biomarker group BEFREE NAB2-STAT6 fusion gene analysis in two cases of meningeal solitary fibrous tumor/hemangiopericytoma with late distant metastases. 25893823 2015
CUI: C1266119
Disease: Solitary fibrous tumor
Solitary fibrous tumor
0.600 Biomarker disease BEFREE NAB2-STAT6 fusion was detected in 34 SFTs. 26686340 2016
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 Biomarker group BEFREE NAB2 exon 4-STAT6 exon 3 fusion correlated with classic SFT morphology and older age and showed a trend toward less mitotic activity; there was also a trend toward more aggressive behavior in tumors lacking NAB2 exon 4-STAT6 exon 3. 26883114 2016
CUI: C1266119
Disease: Solitary fibrous tumor
Solitary fibrous tumor
0.600 Biomarker disease BEFREE NAB2-STAT6 gene fusion is a molecular characteristic of solitary fibrous tumors (SFT) and hemangiopericytoma, underscoring their definition as one diagnostic entity. 28128724 2017
CUI: C0018922
Disease: hemangiopericytoma
hemangiopericytoma
0.380 Biomarker disease BEFREE NAB2-STAT6 gene fusion is a molecular characteristic of solitary fibrous tumors (SFT) and hemangiopericytoma, underscoring their definition as one diagnostic entity. 28128724 2017
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 Biomarker group BEFREE NAB2-STAT6 fusion was detected in 99 of 111 successfully tested tumors (89%) including the single STAT6 immunonegative tumor. 30584643 2019
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.040 Biomarker group BEFREE NAB 2-Expressing Cancer-Associated Fibroblast Promotes HNSCC Progression. 30893927 2019
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.040 Biomarker group BEFREE NAB 2-Expressing Cancer-Associated Fibroblast Promotes HNSCC Progression. 30893927 2019
Squamous cell carcinoma of the head and neck
0.020 Biomarker disease BEFREE NAB2 was detected in interstitial CAFs in primary and metastatic lymph node tissues of HNSCC patients. 30893927 2019
CUI: C1266119
Disease: Solitary fibrous tumor
Solitary fibrous tumor
0.600 Biomarker disease BEFREE A recurrent intrachromosomal rearrangement on chromosome 12q in solitary fibrous tumor leads to the formation of a NAB2-STAT6 fusion oncogene. 24457460 2014
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 Biomarker group BEFREE All tumors were positive for NAB2-STAT6 fusion. 27292373 2017
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 AlteredExpression group BEFREE Although weak correlation was found between EGR-1 and NAB-2 expressions on the whole, NAB-2 expression decreased as tumors dedifferentiated, and inhibition of DNA methyltransferase/histone deacetylase increased NAB-2 expression in lung cancer cells despite no epigenetic alteration in the NAB-2 promoter. 20489156 2010
CUI: C1266119
Disease: Solitary fibrous tumor
Solitary fibrous tumor
0.600 Biomarker disease BEFREE Analysis in 53 tumors confirmed the presence of 7 variants of this fusion transcript in 29 tumors (55%), representing a lower bound for fusion frequency at this locus and suggesting that the NAB2-STAT6 fusion is a distinct molecular feature of SFTs. 23313954 2013
CUI: C1266119
Disease: Solitary fibrous tumor
Solitary fibrous tumor
0.600 FusionGene disease ORPHANET Analysis in 53 tumors confirmed the presence of 7 variants of this fusion transcript in 29 tumors (55%), representing a lower bound for fusion frequency at this locus and suggesting that the NAB2-STAT6 fusion is a distinct molecular feature of SFTs. 23313954 2013
CUI: C1266119
Disease: Solitary fibrous tumor
Solitary fibrous tumor
0.600 Biomarker disease CTD_human Analysis in 53 tumors confirmed the presence of 7 variants of this fusion transcript in 29 tumors (55%), representing a lower bound for fusion frequency at this locus and suggesting that the NAB2-STAT6 fusion is a distinct molecular feature of SFTs. 23313954 2013
CUI: C1266119
Disease: Solitary fibrous tumor
Solitary fibrous tumor
0.600 Biomarker disease BEFREE Another useful discovery was that the NAB2-STAT6 fusion is characteristic of solitary fibrous tumors. 26811225 2016
CUI: C1266119
Disease: Solitary fibrous tumor
Solitary fibrous tumor
0.600 Biomarker disease BEFREE Asymptomatic normal-coloured submucosal nodules located in the buccal mucosa and tongue in adult patients are suggestive of oral solitary fibrous tumour, but only a careful microscopic examination can differentiate benign from malignant variants and the use of immunohistochemistry (CD34, Bcl-2, CD99 and STAT6), and cytogenetic studies (NAB2-STAT6) contribute significantly to confirm the diagnosis of solitary fibrous tumour in difficult cases. 31424136 2020